Introduction
The purpose of this report is to analyse papers written in the last twenty years which claim to demonstrate a cause-and-effect relationship between the ingestion of aspirin and massive gastrointestinal hemorrhage. Since no direct biological cause for such a relationship has been found most of the evidence is circumstantial or epidemiological in nature. The relevant biological and epidemiological papers have been analysed in the light of the nine criteria suggested by Sir Austin Bradford Hill in 1965 as guidelines for deducing whether a cause-and-effect relationship exists, given that an association has been found between certain environmental conditions and a certain disease.
The nine criteria are the strength of the association, the consistency of the association, the specificity of the association to a particular type or site of disease, the temporality of the association (i.e. does the disease lead to the choice of environmental conditions rather than the other way round?), the biological gradient (or dose response) of the association, the biological plausibility of the association. the coherence of a cause-and-effect interpretation of the data with other known facts concerning the disease, the experimental evidence in support of a cause-andeffect relationship, and analogies with other environmental conditions which are proven as causes of the disease.
Strength ofthe Association
The following tables summarize the results of thirteen epidemiological studies where patients who had been admitted to hospital for massive gastrointestinal bleeding were questioned about their aspirin intake prior to the onset of symptoms leading to admission. In many of the studies a control group of patients were also questioned about their aspirin intake. The aspirin intake took the form of aspirin tablets or of compounds containing aspirin.
In Table 1 are summarized the percentages of patients who had taken aspirin within 24 hours of onset of symptoms or admission to hospital, or, in the case of one control group, attendance as new patients at a clinic. Taking the gastric haemorrhage group as a whole, in the four studies Table I Percentages of patients who had ingested aspirin during the 24 hours prior to admission or visit to clinic Study Muir & Cossar (1955) Scotland 1949-55 Brown & Mitchell (1956) Muir & Cossar (1959) 38 ( where control groups exist, significantly more The methods used to question the patients in patients in the hemorrhage groups had ingested the studies are not explained in sufficient detail aspirin than in the control groups. The strength to enable an assessment to be made of whether of this association was less marked in one study, or not all bias has been eliminated. For these Brown & Mitchell (1956) . This study was carried studies to be strictly valid the questioner should be out on negro patients which may account for the unaware of whether the patient has been admitted different degree of association found. Apart from to hospital for gastrointestinal bleeding or for this study, the proportions of patients in the some other reason. Otherwise an unconscious heemorrhage groups who had taken aspirin were bias may be introduced into the care taken over well over double those in the control groups. questioning the bleeders as opposed to the However, all the control groups used in these controls. This is an important point because studies are open to criticism. The control groups, many people are unaware that certain proprietary described in Table 1 , all consist of hospital medicines contain aspirin. patients, either inpatients or outpatients. As such, It is of interest to note that if the gastrothey may well have been on drug therapy previous intestinal bleeders are divided into two groups, to their admission to hospital or attendance at namely those with acute lesions or with no lesion clinic which precluded or discouraged them from found (unexplained) and those diagnosed as taking aspirin. Furthermore, if they suffered from having peptic ulcers, a larger percentage of the gastric symptoms they may have been advised patients in the acute lesion group are found to against taking aspirin. Finally, aspirin ingestion have ingested aspirin than in the peptic ulcer itself may prevent certain diseases from developgroup, the ratio of the percentages being generally ing; there is evidence that aspirin therapy may be about 3:2. This might occur because some of the an aid to the prevention of myocardial infarction ulcer patients, having a history of dyspepsia, (Elwood 1975 , Levy 1974 .
would avoid taking aspirin. Parry & Wood (1967) 54**C to 63*** 80) 74*** to 83**C ( In Table 2 , which shows the percentages of patients who had ingested aspirin within the 48 hours prior to admission or onset ofsymptoms, the same kind of pattern emerges, if anything, more strongly. Where control groups exist, there are significant differences at the 0.1 % level between the percentages of patients in the heemorrhage groups who had taken aspirin and the percentages in the control groups. The ratios of the percentages are more than 2:1 and, in one study, Muir & Cossar (1959) , more than 3:1. As in Table 1 , the acute lesion groups had higher percentages of aspirin takers than the peptic ulcer groups.
The same patterns of associations are seen in Tables 3, 4 and 5 which summarize the aspirin ingestion of patients in the 72 hours, the 96 hours and one week prior to admission or onset of symptoms. It is of interest to note that in the Parry & Wood (1967) investigation (Table 5) , if patients with cardiovascular, gastrointestinal, neurological and heematological disorders are excluded from the control group, the percentage of patients ingesting aspirin within a week of admission increases from 32 to 50. In the Allibone & Flint (1958) study shown in Table 6 only the acute lesion group is significantly different from its control group. In this study the patients were questioned about their aspirin consumption during the previous fortnight. The patients in the control groups were matched with the bleeders for sex and age and seem to be more valid controls than those in the other studies.
Percentages of patients in the different groups who were 'heavy users' of aspirin are compared in Table 7 . The criterion for a patient to be a heavy user varies from study to study but generally implies almost daily consumption for a varying time period prior to admission. There are significantly more heavy users in the acute lesion plus unexplained haemorrhage groups than in the control groups but only in the Kelly (1956) study are there significantly more heavy users in the peptic ulcer group. However, since the control group in this study consisted of patients admitted for myocardial infarction not too much weight should be given to this significant difference. In his study Levy (1974) omitted all patients with a history of peptic ulcer both from the hlimorrhage groups and from the control group. He also excluded patients with a medical history likely to be associated with gastric problems or with the occurrence of hvmorrhages. In addition, amongst the controls. he excluded patients whose primary discharge diagnoses included any form of disease likely to be associated with aspirin consumption, Although these thirteen studies indicate definite association between aspirin ingestion and massive gastrointestinal bleeding (himatemesis or melhna) amongst the many patients questioned in the different studies, the control groups are open to criticism and thus the evidence for an association cannot be regarded as conclusive. However, the proportions of patients admitted to hospital for haematemesis or melkna do seem high and worth further investigation.
Consistency ofAssociation
It can be seen from Table 1 that the percentage of gastrointestinal htemorrhage patients ingesting aspirin within the twenty-four hours prior to admission or onset of symptoms varies among the seven studies from 38 to 67. However, in five of the seven studies this percentage lies between 40 and 50. These results are reasonably consistent considering they were obtained in different parts of the world, namely England, Scotland, North America and Norway. All these studies were carried out in the 1950s or early 1960s. The higher percentage of patients consuming aspirin in the Astley (1967) study may be explained by the fact that special care was taken in this study, when questioning patients, to inform them of the 321 proprietary medicines that contain aspirin. Many patients were found to be unaware that some common proprietary medicines such as Alka-Seltzer contained aspirin. There is no obvious explanation for the lower percentages found in the Muir & Cossar (1959) study.
The ratios of the percentages on the acute lesion groups to the peptic ulcer groups are also very consistent considering the methods of diagnosis were not the same in all studies. The percentages of patients in the four control groups who had ingested aspirin were very similar apart from the percentage in the Alvarez & Summerskill (1958) study which was rather lower. This control group was made up of outpatients attending a clinic for dyspepsia and differed markedly from the other control groups which were made up of inpatients not, generally, suffering from gastric symptoms.
The results in Table 2 are also consistent but in Table 3 the study carried out by Needham et al. (1971) is out of line with the other studies. Only 29% of patients with haemorrhages were found to have ingested aspirin compared with 53 % to 63 % in the other two studies. A possible explanation for this lower figure is that aspirin ingestion habits changed during the 1960s. In fact yearly consumption of aspirin and aspirincontaining products fell during the 1960s (Langman 1976) but the population of England and Wales increased by 6% and the population of Scotland by 1 % (census figures). Furthermore, the hospital admissions of patients with hematemesis or melina (cause unknown) rose by 32% during the 1960s (Langman 1974 Table 4 also produced lower percentages of patients consuming aspirin but not so markedly. However, the data for this study were collected throughout the 1960s (including the data gathered by Wood in 1961 and 1962 ) so one would not expect the drop in aspirin consumption to appear so marked as in the Needham et al. study.
In Table 7 the heavy users of aspirin are defined differently in different studies. In the Kelly (1956) study in New York they are defined as patients who were found, from case notes, to be on salicylate therapy for other causes when admitted to hospital. In the Lange (1957) study in Norway they are defined simply as 'addicts' (though the aspirin intake for each 'addict' is given and varies from 'one now and then for years' to '2-6 daily for years'), in the Parry & Wood (1967) study in England they are defined as patients who took aspirin every day for a week before admission, and in the Levy (1974) Table 7 Percentages of patients who were heavy users of aspirin Study Kelly (1956) New York 1952-56 Lange (1957) Norway 1955-56 Parry & Wood (1967) Middlesex 1961-62 Levy (1974) study they are patients who have taken aspirin for four or more days a week for at least three months prior to admission. Bearing these differences in mind, the pattern of results is inconsistent. In all the tables the ratios of percentages of aspirin takers in the acute lesion groups to the percentages in the peptic ulcer groups re,main fairly constant, especially when one takes into account the fact that the ratios of the numbers of patients falling into these two subcategories vary considerably from study to study. The ratio is as low as 0.19:1 in the Needham et al. (1971) study and as high as 1.21:1 in the Jennings (1965) study. The ratio reaches 2:1 in the Levy (1974) study but this is probably because he excludes all patients with a history of peptic ulcer.
Generally speaking, the results of the thirteen studies are consistent but there is a tendency to smaller proportions of aspirin consumers being found in the later studies.
Specificity ofAssociation
The studies summarized in Tables 1-7 are all concerned specifically with the association between aspirin ingestion and htmatemesis or melena. In addition aspirin is known to be a gastric irritant. It damages the gastric mucosa and causes erosions and occult bleeding. Epidemiological evidence associating aspirin ingestion with peptic ulcer formation and with breakdown of peptic ulcer has been given by Muir & Cossar (1955) , Douglas & Johnston (1961), Gillies & Skyring (1968 , 1969 , Chapman & Duggan (1969) and Levy (1974) . Most of these studies are unconvincing for the same reasons as the studies associating aspirin ingestion with massive gastrointestinal hTemorrhages are unconvincing. However, the study by Gillies & Skyring (1969) , which uses other workers in the same factories as ulcer patients as controls, is more convincing. Contrary evidence which denies the association of aspirin ingestion with recurrence of gastric ulcer has been provided by Piper et al. (1975) .
There is also experimental evidence for therapeutic doses of aspirin prolonging bleeding times (Frick 1956 , Gast 1964 , Quick 1966 ) and reducing platelet stickiness (Gast 1964) . Contrary evidence was given by Alvarez & Summerskill (1958) . Russell et al. (1968) found associations between depressed leukocyte-ascorbic acid levels in patients and the occurrence of massive gastrointestinal haemorrhages and between depressed ascorbic acid levels and the ingestion of aspirin. Decreased ascorbic acid levels lead to increased capillary fragility (Anderson 1953 ) and thus to a tendency to hemorrhage.
All the evidence on the side effects of therapeutic doses of aspirin is therefore specific to the local irritant effects of aspirin on the stomach and duodenum and to the systemic effects of aspirin on ascorbic acid levels and bleeding times, which may be contributory to the causation of gastrointestinal hemorrhages. Toxic doses of aspirin produce many other effects but these are not of relevance to this study.
Temporality ofthe Association Assuming that there exists an association between aspirin ingestion and the occurrence of hematemesis and melhna, is this a cause-and-effect relationship or not? An alternative explanation of such an association might be that it is a 'cart before the horse' situation, i.e. that patients take aspirin to ameliorate symptoms which are, in fact, the initial symptoms of a hemorrhage. Yet another explanation might be that both the aspirin consumption and the hmmorrhage were caused by some third factor. In some investigations efforts were made to investigate the 'cart before the horse' theory. Muir & Cossar (1955) diagnosed aspirin as definitely the cause of bleeding in patients who had rarely, if ever, taken aspirin before the occasion prior to bleeding. They found 13% of the patients who bled fell into this category. However, why did these patients take aspirin, a very unusual step for them? Could the symptoms that had caused them to take aspirins be linked with hemorrhage, e.g. headache or stomach pain? In a later study Muir & Cossar (1959) again diagnosed 13% of the haemorrhage cases to have been definitely caused by aspirin. Waterson (1955) obtained the aspirin history of 151 patients and found that in 3 cases, or 2%, there was reasonably good evidence that aspirin could be incriminated as the cause ofheemorrhage. This is a rather more cautious figure than that of Muir & Cossar. Jennings (1965) investigated the history of aspirin consumption in hemorrhage patients together with other factors thought to be related to the occurrence ofgastrointestinal hwmorrhages. He questioned patients admitted for haematemesis and melaena concerning the presence or absence of the following factors in their recent history: aspirin ingestion, nervous strain, physical strain, smoking, alcohol consumption, acute infections, chronic infections, arteriosclerosis and hypertension. His results are summarized in Table 8 . It can be seen that quite large proportions of patients were positive for many of these factors, all of which are considered to be contributory to the occurrence of gastrointestinal haemorrhages.
On carrying out chi-square tests of association between aspirin ingestion and each of the other factors, both overall and broken down by diagnosis group and sex, I found only one positive association. This was the association between aspirin ingestion and the presence of acute infections (P<0.001), the great majority of which were respiratory tract infections. This association is to be expected since aspirin is the common medicine taken to relieve the symptoms of influenza type illnesses. A negative association was found between aspirin ingestion and nervous hypertension strain (P<0.01) amongst females diagnosed as having chronic peptic ulcers, and between aspirin ingestion and physical strain (P<0.05) amongst males in the acute lesion group. This lack of a positive association of aspirin with any of these factors except acute infections argues against there being a single third factor which causes both aspirin consumption and gastrointestinal hamorrhage or which, in combination with aspirin consumption, causes gastrointestinal hemorrhages. On the other hand, the numbers of patients suffering from each of these factors are so large as to make it unlikely that there were many patients who ingested aspirin who did not also suffer from one or more of the other predisposing factors. Unfortunately the actual figure is not available in Jennings's paper. More unfortunately he did not have any control group in his study. Conflicting evidence in the association between aspirin ingestion and alcohol consumption has been provided by Brown & Mitchell (1956) , who found a strong negative association amongst their hwemorrhage patients; by Astley (1967) , who found no association; and by Needham et al. (1971) who found a strong positive association.
Thus the problem of the temporality of the association has not been solved though it would appear that there is no single third factor which leads to both aspirin consumption and hmemorrhages or which is exacerbated by aspirin consumption into causing hemorrhages. However, there may be multiplicity of such factors.
Biological Gradient ofthe Association
There is no evidence for a dose-related response of the occurrence of a massive gastrointestinal hmmorrhage to the number of aspirins consumed prior to admission to hospital. Levy (1974) did find a higher proportion of patients in the hEemorrhage group regularly taking aspirin for four or more days a week than in the control group (P<O.O1) and did not find a similar significant association amongst the light users. However, it could be argued that the association found amongst the heavy users is a 'cart before the horse' situation. A dose-response relationship was found for occult bleeding by Pierson et al. (1961) but not by Scott et al. (1961) . Thus there is no clear cut biological gradient in the association.
Plausilility oJ the Association
It is biologically plausible that aspirin consumption is a cause of massive gastrointestinal hemorrhage. Aspirin is a proven gastric irritant and has been incriminated as a possible cause of ulcer formation. Aspirin has also been shown to affect bleeding times and to be associated with the depletion of leukocyte-ascorbic acid levels. A reduction in these ascorbic acid levels leads to an increased capillary fragility and a tendency to hemorrhage. However, the tendency to occult bleeding does not differ amongst those who have suffered from hematemesis or mehena or amongst those who suffer from dyspepsia or ulcers from amongst healthy individuals. Consequently the fact that aspirin causes occult bleeding does not necessarily imply that it causes overt bleeding.
Experimental evidence against systemic effects alone being a cause of occult bleeding has been given by Cooke & Goulston (1969) and Leonards & Levy (1970) but in the case of aspirin ingestion we are concerned with a combination of both local and systemic effects.
C(oherence ofthe Evidencefor the Association
The existence of a cause-and-effect relationship between aspirin ingestion and the occurrence of haematemesis or meleena would not conflict with the biological facts known about the disease. Historical facts about the disease, however, do not support such a cause-and-effect relationship. The aspirin consumption per head of population decreased in the 1960s but the hospital admissions for hamatemesis and melena (cause unknown) in England and Wales increased by about 32% and the population by only 6 %. The increase in admissions for gastrointestinal hemorrhages is being caused by some factors or factor other than aspirin, and aspirin's role, if any, is diminishing.
Experimental Evidencefor the Association
There is no experimental evidence available in humans or animals for aspirin ingestion as the cause of massive gastrointestinal hemorrhages.
Analogies with other Drugs known to cause Massive HIkmorrhages No such analogies have been made.
Conclusion
If the criteria suggested by Sir Austin Bradford Hill for deducing a cause-and-effect relationship between environment and a specific disease are adhered to, then the evidence reviewed in this paper does not constitute proof of such a relationship between aspirin ingestion and the occurrence of massive gastrointestinal bleeding. Any future investigations should be carefully planned to take into account the factors mentioned in this review, i.e. suitable controls, solution of the temporality problem and a search for other factors leading to both aspirin ingestion and hemorrhages. Some of these problems might be overcome by looking at the proportions of haemorrhage patients and controls who have consumed other analgesics such as paracetamol (bearing in mind that aspirin and paracetamol consumers are self-selected).
